Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schrijver, Lieske
31  Ergebnisse:
Personensuche X
?
1

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers..:

Schrijver, Lieske H ; Mooij, Thea M ; Pijpe, Anouk...
JNCI: Journal of the National Cancer Institute.  114 (2022)  4 - p. 540-552 , 2022
Link: https://doi.org/10.1093/..
 
?
2

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske H. ; Antoniou, Antonis C. ; Olsson, Håkan...
American Journal of Obstetrics and Gynecology.  225 (2021)  1 - p. 51.e1-51.e17 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Ovarian stimulation for IVF and risk of primary breast canc..:

HEBON ; Derks-Smeets, Inge A. P. ; Schrijver, Lieske H....
British Journal of Cancer.  119 (2018)  3 - p. 357-363 , 2018
Link: https://doi.org/10.1038/..
 
?
4

Oral Contraceptive Use and Breast Cancer Risk: Retrospectiv..:

Schrijver, Lieske H ; Olsson, Håkan ; Phillips, Kelly-Anne...
JNCI Cancer Spectrum.  2 (2018)  2 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
5

Use of Exogenous Hormones and Risks of Breast and Ovarian C..:

Schrijver, Lieske H. ; Jansen, Susanne ; van der Baan, Frederieke H..
Current Breast Cancer Reports.  6 (2014)  2 - p. 121-131 , 2014
Link: https://doi.org/10.1007/..
 
?
6

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske ; Antoniou, Antonis ; Olsson, Håkan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajog.2021.01.014.  , 2021
Link: https://hal.science/hal-..
 
?
7

Oral Contraceptive Use and Breast Cancer Risk: Retrospectiv..:

Schrijver, Lieske ; Olsson, Håkan ; Phillips, Kelly-Anne...
info:eu-repo/semantics/altIdentifier/doi/10.1093/jncics/pky023.  , 2021
Link: https://www.hal.inserm.f..
 
?
8

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske ; Antoniou, Antonis ; Olsson, Håkan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajog.2021.01.014.  , 2021
Link: https://hal.science/hal-..
 
?
9

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske ; Antoniou, Antonis ; Olsson, Håkan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajog.2021.01.014.  , 2021
Link: https://hal.science/hal-..
 
?
10

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske ; Antoniou, Antonis ; Olsson, Håkan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajog.2021.01.014.  , 2021
Link: https://hal.science/hal-..
 
?
11

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske ; Antoniou, Antonis ; Olsson, Håkan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajog.2021.01.014.  , 2021
Link: https://hal.science/hal-..
 
?
12

Oral contraceptive use and ovarian cancer risk for BRCA1/2 ..:

Schrijver, Lieske ; Antoniou, Antonis ; Olsson, Håkan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajog.2021.01.014.  , 2021
Link: https://hal.science/hal-..
 
?
13

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers..:

Schrijver, Lieske H ; Mooij, Thea M ; Pijpe, Anouk...
https://research.rug.nl/en/publications/97775387-722b-4300-a406-98274a506ab8.  , 2022
Link: https://hdl.handle.net/1..
 
?
14

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers..:

Schrijver, Lieske H ; Mooij, Thea M ; Pijpe, Anouk...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002279/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Oral Contraceptive Use and Breast Cancer Risk: Retrospectiv..:

Schrijver, Lieske, H ; Olsson, Håkan ; Phillips, Kelly-Anne...
info:eu-repo/semantics/altIdentifier/doi/10.1093/jncics/pky023.  , 2021
Link: https://inserm.hal.scien..
 
1-15